A rise in the levels of parathyroid hormone (PTH) in the blood is the hallmark of hyperparathyroidism. This can be the result of a problem inside the parathyroid glands themselves (a condition known as primary hyperparathyroidism) or a reaction to factors in the environment (secondary hyperparathyroidism). The increased synthesis of parathyroid hormone is responsible for the symptoms of hyperparathyroidism, which are produced by abnormally normal or raised blood calcium levels. This occurs as a result of calcium leaving the bones and flowing into the bloodstream. It is normal for the levels of parathyroid hormone in healthy persons to be low while the levels of blood calcium are high. Kidney stones are the most prevalent sign of hyperparathyroidism that has been present for a long time. Additional symptoms may include discomfort in the bones, weakness, sadness, disorientation, and an increase in the amount of urine passed. Osteoporosis can be the outcome of either primary or secondary causes (weakening of the bones).
Primary hyperparathyroidism is caused, in around eighty percent of instances, by a single benign tumor known as a parathyroid adenoma. The vast majority of the remaining can be attributed to a number of these adenomas. In extremely rare cases, it might be caused by malignancy of the parathyroid gland. In most cases, secondary hyperparathyroidism is brought on by a lack of vitamin D, chronic renal illness, or some other condition that brings about low blood calcium levels. The presence of both increased calcium levels and PTH levels in the blood is required to make a diagnosis of primary hyperparathyroidism.
The only possible treatment for primary hyperparathyroidism is the surgical removal of the adenoma or the hyperactive parathyroid glands. In those who don’t have any symptoms, ensuring that their kidneys and bone density are healthy and that their blood calcium levels are just slightly elevated may be sufficient. Although it is not a cure, the medicine cinacalcet can be used to lower PTH levels in patients who are unable to undergo surgery to treat their condition. Large quantities of intravenous normal saline could be part of the treatment plan for patients who have extremely high calcium levels in their blood. Low levels of vitamin D before surgery are a contentious topic for patients who have primary hyperparathyroidism; nevertheless, low levels of vitamin D should be rectified in individuals who have secondary hyperparathyroidism. After a parathyroidectomy, patients should have their vitamin D levels checked and treated if they are low.
The most prevalent kind of hyperparathyroidism is known as primary hyperparathyroidism. One to four out of every thousand persons is afflicted with this condition in wealthy countries. It strikes women three times more frequently than it does males, and a diagnosis of it is typically made between the ages of 50 and 60, though it can happen earlier in life.
In primary hyperparathyroidism, around 75% of patients do not exhibit any symptoms. Although the majority of primary patients are asymptomatic at the time of diagnosis, the term “asymptomatic” is not well defined and primarily refers to those individuals who do not have “obvious clinical sequelae,” such as kidney stones, bone disease, or hypercalcemic crises. These “asymptomatic” people could still be experiencing other symptoms, such as anxiety, sadness, gastrointestinal distress, or neuromuscular issues, but these are not considered to be symptoms of the condition. The issue is frequently discovered by accident while the patient is getting blood work done for another reason, and the results of the tests reveal an abnormally high concentration of calcium in the blood. There are a lot of folks who merely have general symptoms.
Symptoms of hypercalcemia that are common include feelings of weakness and fatigue, depression, bone pain, muscle soreness (myalgias), decreased appetite, feelings of nausea and vomiting, constipation, pancreatitis, polyuria, polydipsia, cognitive impairment, kidney stones, vertigo, and osteopenia or osteoporosis. Other symptoms include cognitive impairment, pancreatitis, polyuria, polydipsia, and polydipsia. The presence of racquet nails, also known as brachyonychia, in a patient’s medical history may be suggestive of bone resorption. The presence of a rugger jersey spine is a radiographic feature that can be used to diagnose hyperparathyroidism. On clinical examination, adenomas of the parathyroid gland are extremely difficult to identify. The majority of people get relief from their symptoms after undergoing surgery to have a parathyroid tumor removed.
The parathyroid gland is functioning correctly when secondary hyperparathyroidism is caused by a deficiency in the body’s ability to absorb vitamin D. The clinical difficulties are caused by bone resorption and appear in the form of bone disorders such as rickets, osteomalacia, and renal osteodystrophy.
Classifications of Hyperparathyroidism
Primary
Parathyroid adenoma.
Primary hyperparathyroidism is a condition that develops when the parathyroid glands themselves begin to overproduce hormones. PTH overproduction can be caused by a parathyroid adenoma, parathyroid hyperplasia, or, in extremely rare cases, parathyroid cancer. This condition is sometimes described using the phrase “stones, bones, moans, and mental undertones.” These symptoms allude, in order, to the presence of kidney stones, hypercalcemia, constipation, and peptic ulcers, as well as depression.
In a small percentage of cases, this occurs as part of a multiple endocrine neoplasia (MEN) syndrome, either type 1 (caused by a mutation in the gene MEN1) or type 2a (caused by a mutation in the gene RET), which is also associated with the adrenal tumor pheochromocytoma. Both types are caused by mutations in the MEN1 and RET genes, respectively. Mutations in the genes HRPT2 and CASR have also been found to be associated with parathyroid neoplasia. Other mutations that have been connected to this condition include:
Patients who suffer from bipolar illness and are taking lithium for an extended period of time are at an elevated risk of developing hyperparathyroidism. Patients who have been using lithium for an extended period of time have a 15β20 percent increased risk of developing calcium hypercalcemia. However, only a small percentage of these individuals have levels of parathyroid hormone that are highly increased and clinical symptoms consistent with hyperparathyroidism. The majority of the time, a solitary parathyroid adenoma is to blame for lithium-associated hyperparathyroidism.
Secondary
The release of parathyroid hormone (PTH) by the parathyroid glands in reaction to hypocalcemia is the cause of secondary hyperparathyroidism. This means that the PTH secretion is physiological, or appropriate (low blood calcium levels). Vitamin D insufficiency is by far the most prevalent cause of this condition. (which can be brought on by a lack of exposure to sunshine, a poor diet, or malabsorption), as well as chronic renal failure.
Insufficiency in vitamin D results in decreased calcium absorption by the gut, which in turn causes hypocalcemia and a rise in the release of parathyroid hormone. This results in an increased rate of bone resorption. The specific issue that arises in patients who have chronic renal failure is an inability of their kidneys to convert vitamin D to its active form. Renal osteodystrophy is the name given to the bone disease that occurs as a result of secondary hyperparathyroidism brought on by kidney failure.
Tertiary
People who have had secondary hyperparathyroidism for a long period of time may develop tertiary hyperparathyroidism. This condition occurs when the parathyroid glands become hyperplastic and lose their ability to respond to changes in circulating calcium levels. This condition is an independent activity and is found most frequently in people who have renal disease that has progressed to its last stages.
This video depicts all the key features of Primary Hyperparathyroidism
I am Dr Shashikant, a pathologist,professor and medical writer by profession. Please contact-ruc.isha@gmail.comΒ for medical writing, Pathology online tutoring for usmle,neetpg,plab,fmge,mbbs,md